A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors

A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors

Abstract Identifying women at high risk of osteoporotic fracture from aromatase inhibitor (AI) therapy for breast cancer is largely based on known risk factors for healthy postmenopausal women, which might not accurately reflect the risk in breast cancer patients post-AI therapy. To determine whethe...

Full description

Bibliographic Details
Main Authors: Christine Hook, Udit Chatterjee, Haiyang Sheng, Qianqian Zhu, Timothy Robinson, Janise M. Roh, Cecile A. Laurent, Catherine Lee, Jennifer Delmerico, Joan C. Lo, Christine B. Ambrosone, Lawrence H. Kushi, Marilyn L. Kwan, Song Yao
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-024-00615-9

Internet

https://doi.org/10.1038/s41523-024-00615-9

Similar Items